496 results
S-8
EX-3.1
BAX
Baxter International Inc.
7 May 24
Registration of securities for employees
4:31pm
, the commencement, prosecution, or defense of any litigation, and the seeking of injunctive relief in such litigation).
I. Board-Solicited Stockholder Action
8-K
EX-99.1
BAX
Baxter International Inc.
2 May 24
Baxter Reports First-quarter 2024 Results
7:17am
, withdrawals, launch delays, warning letters, import bans, sanctions, seizures, litigation or declining sales, including the focus on evaluating product … , taxation and rebate policies; the outcome of pending or future litigation; the impact of competitive products and pricing, including generic competition
8-K
EX-10.3
BAX
Baxter International Inc.
21 Mar 24
Entry into a Material Definitive Agreement
4:32pm
limitation, in connection with any workout, restructuring, enforcement of remedies, bankruptcy proceedings or litigation among the Administrative Agent
8-K
ip8vwu 7i2jwsl
4 Mar 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
qwe 2gl9hbi
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
8-K
EX-99.1
zhyt69hpndh27p 5n2b
2 Nov 23
Baxter Reports Third-quarter 2023 Results
7:18am
8-K
vk18astc9q4jg2itoeak
2 Oct 23
Completion of Acquisition or Disposition of Assets
9:02am
8-K
EX-99.1
454rk9nl4mv1mo g57
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
EX-99.1
giaue
6 Jul 23
Regulation FD Disclosure
8:30am
SD
EX-1.01
9bg0ml0j9sfu22i e1
31 May 23
Conflict minerals disclosure
4:36pm
8-K
EX-2.1
oqt qq65yi
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-99.1
9r2 jtd11405z
27 Apr 23
Baxter Reports First-quarter 2023 Results
7:18am